Elinor Shin was Appointed as Vice President Intellectual Property at MyoKardia

Date of management change: October 12, 2018 

What Happened?

South San Francisco, California-based MyoKardia Appointed Elinor Shin as Vice President Intellectual Property


About the Company

Our Mission: Change the world for patients with cardiovascular disease through bold and innovative science. MyoKardia is a clinical stage biopharmaceutical company pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. Our initial focus: treatment of heritable cardiomyopathies, a group of genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. We are a growing community of employees who enjoy working with and learning from each other. We collaborate in a way that ensures the growth of the company as well each employee individually. MyoKardia is committed to creating a culture that`s centered on our core values. We seek individuals who not only offer expertise in their respective fields, but can serve as cultural leaders and role models for our values.


About the Person

Elinor Shin is Vice President Intellectual Property at MyoKardia. Previously, Elinor held various senior legal leadership roles in the industry.


Info Source



Other IT executives who recently changed jobs as well: Salen Stuart, Stefani Anthony, Morgan Keith, Checchio Leigh, Walsh Derek, Poon Herbert, Ortega Jennifer, Carrillo Andres, Carlson Michael, Kohler Susan, Brown Kevin

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.